FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
about
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancerUpregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinomaCentrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway.Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cells.High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerCEP55 Promotes Cell Motility via JAK2⁻STAT3⁻MMPs Cascade in Hepatocellular Carcinoma
P2860
Q33688594-2C07F9A4-6831-41CC-A3B5-53008E14A2EBQ35080861-EDBE9E5B-1C8A-4714-BAC4-E80F793AE400Q35493637-CD304491-23AB-405C-94FF-21FECCCB67E8Q36922664-81C4D4A7-CFA1-4388-AF4A-63E82FAFDB22Q37133643-27FE8582-B1D0-4733-9C6B-C799473E9404Q38444145-1CF05EDA-8DD6-44BD-8006-5E15C6AE19C4Q38797778-5E5BF9CE-43B7-4113-8DB5-0C08943478CCQ38838413-75240AE7-25AF-46C7-8C8C-C5D6FF313AA8Q54982027-FC5951AA-4F85-4563-8A19-D00437F5CEDCQ55014124-F769860D-51EB-40B8-90A5-2430EAABA643Q58779939-53A48B23-543F-423C-B106-DBC9E92EC3E8Q58795154-B03A6125-9205-433E-BDA0-2E5A6E2ED6CE
P2860
FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@ast
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@en
type
label
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@ast
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@en
prefLabel
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@ast
FLJ10540 is associated with tu ...... via osteopontin/CD44 pathway.
@en
P2093
P2860
P356
P1476
FLJ10540 is associated with tu ...... s via osteopontin/CD44 pathway
@en
P2093
Chang-Han Chen
Chao-Cheng Huang
Chi-Ying F Huang
Chung-Feng Hwang
Fu-Min Fang
Hong-Chang Kang
Hsin-Ting Tsai
Li-Yen Shiu
Shun-Chen Huang
Wan-Chu Chuang
P2860
P2888
P356
10.1186/1479-5876-10-93
P50
P577
2012-05-16T00:00:00Z
P5875
P6179
1009619117